Personalis, Inc. (NASDAQ:PSNL) Receives $7.67 Average Price Target from Brokerages

Shares of Personalis, Inc. (NASDAQ:PSNL - Get Free Report) have been given an average rating of "Buy" by the six ratings firms that are presently covering the stock, Marketbeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year price target among brokers that have issued a report on the stock in the last year is $7.67.

A number of research firms have recently weighed in on PSNL. Needham & Company LLC restated a "buy" rating and issued a $7.00 target price on shares of Personalis in a report on Thursday, April 10th. HC Wainwright raised their target price on Personalis from $8.00 to $9.00 and gave the company a "buy" rating in a report on Wednesday, May 7th. Finally, Guggenheim began coverage on Personalis in a research report on Thursday, May 15th. They set a "buy" rating and a $6.00 price target for the company.

Institutional Investors Weigh In On Personalis

Several hedge funds have recently added to or reduced their stakes in the company. Royal Bank of Canada raised its position in Personalis by 3.2% during the 1st quarter. Royal Bank of Canada now owns 78,341 shares of the company's stock valued at $275,000 after purchasing an additional 2,395 shares during the last quarter. China Universal Asset Management Co. Ltd. grew its holdings in shares of Personalis by 18.2% during the 1st quarter. China Universal Asset Management Co. Ltd. now owns 17,704 shares of the company's stock worth $62,000 after acquiring an additional 2,724 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Personalis during the 4th quarter worth approximately $28,000. Stifel Financial Corp grew its holdings in shares of Personalis by 25.0% during the 4th quarter. Stifel Financial Corp now owns 25,000 shares of the company's stock worth $144,000 after acquiring an additional 5,000 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in shares of Personalis by 2,827.0% during the 4th quarter. JPMorgan Chase & Co. now owns 5,854 shares of the company's stock worth $34,000 after acquiring an additional 5,654 shares during the period. Institutional investors own 61.91% of the company's stock.

Personalis Stock Performance

Shares of PSNL stock traded down $0.01 on Tuesday, hitting $5.48. The company had a trading volume of 301,042 shares, compared to its average volume of 1,051,742. The firm has a market cap of $483.55 million, a P/E ratio of -4.24 and a beta of 1.95. The stock's 50-day moving average is $6.05 and its two-hundred day moving average is $4.92. Personalis has a twelve month low of $2.81 and a twelve month high of $7.79.

Personalis (NASDAQ:PSNL - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.05. The business had revenue of $20.61 million during the quarter, compared to analysts' expectations of $17.41 million. Personalis had a negative return on equity of 48.78% and a negative net margin of 98.10%. Equities research analysts predict that Personalis will post -1.4 EPS for the current year.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.